As of 2025-07-03, the Intrinsic Value of AlzChem Group AG (ACT.DE) is 125.47 EUR. This ACT.DE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 133.00 EUR, the upside of AlzChem Group AG is -5.70%.
The range of the Intrinsic Value is 83.82 - 306.40 EUR
Based on its market price of 133.00 EUR and our intrinsic valuation, AlzChem Group AG (ACT.DE) is overvalued by 5.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 83.82 - 306.40 | 125.47 | -5.7% |
| DCF (Growth 10y) | 87.26 - 295.05 | 126.56 | -4.8% |
| DCF (EBITDA 5y) | 61.74 - 78.37 | 68.27 | -48.7% |
| DCF (EBITDA 10y) | 71.76 - 95.18 | 81.20 | -38.9% |
| Fair Value | 138.69 - 138.69 | 138.69 | 4.28% |
| P/E | 58.68 - 76.33 | 68.34 | -48.6% |
| EV/EBITDA | 58.18 - 101.53 | 72.93 | -45.2% |
| EPV | 79.98 - 116.43 | 98.20 | -26.2% |
| DDM - Stable | 56.84 - 304.97 | 180.90 | 36.0% |
| DDM - Multi | 63.75 - 256.22 | 101.00 | -24.1% |
| Market Cap (mil) | 1,353.94 |
| Beta | 0.42 |
| Outstanding shares (mil) | 10.18 |
| Enterprise Value (mil) | 1,262.57 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.73% |
| Cost of Debt | 4.25% |
| WACC | 7.56% |